Extract notice to the Minister
Vosevi
Common name / Subject : sofosbuvir/velpatasvir/voxilaprévir
Name of the manufacturer : Gilead
Form : Co.
Dosage : 400 mg - 100 mg - 100 mg
Name of the manufacturer : Gilead
Form : Co.
Dosage : 400 mg - 100 mg - 100 mg
Indication : Hépatite C chronique
INESSS' Recommendation
-
Minister's decisions
Inscrire aux listes des médicaments - Médicament d’exception
Evaluation published on March 01, 2018